{"data":{"billId":"114-hr-2443","congress":114,"type":"HR","number":"2443","title":"To amend the Federal Food, Drug, and Cosmetic Act with respect to CLIA waiver study design guidance for in vitro diagnostics.","shortTitle":null,"originChamber":"House","introducedDate":"2015-05-19","updateDate":"2025-04-07T15:40:51Z","latestAction":{"actionDate":"2015-05-22","text":"Referred to the Subcommittee on Health."},"policyArea":"Health","sponsors":[{"bioguideId":"G000558","district":2,"firstName":"Brett","fullName":"Rep. Guthrie, Brett [R-KY-2]","isByRequest":"N","lastName":"Guthrie","party":"R","state":"KY","url":"https://api.congress.gov/v3/member/G000558?format=json"}],"cosponsorsCount":0,"committeesCount":1,"actionsCount":4,"textVersionsCount":1,"url":"https://civdotiq.org/bill/114-hr-2443"},"meta":{"apiVersion":"v1","timestamp":"2026-10-04T21:54:19.708Z","source":"congress.gov","license":"MIT","documentation":"https://civdotiq.org/docs/api"}}